---
title: "Spermine–NSAID Conjugate RNP-11 Shows Potent Activity Against MRSA and VRE"
id: "pubmed-42531897"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42531897"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42531897/"
doi: "10.1016/j.ejmech.2026.119181"
published_at: "2026-11-15T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Spermine–NSAID Conjugate RNP-11 Shows Potent Activity Against MRSA and VRE
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42531897
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42531897/)
- **DOI:** [10.1016/j.ejmech.2026.119181](https://doi.org/10.1016%2Fj.ejmech.2026.119181)
- **Published At:** 2026-11-15T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Investigators synthesized conjugates linking **spermine** to various **NSAID** scaffolds to evaluate antibacterial and anti-inflammatory dual action. - One compound, **RNP-11**, a gemini amphiphilic conjugate of spermine and flufenamic acid, showed the strongest activity across the library. - Minimum inhibitory concentrations (MICs) for **RNP-11** ranged from 2–4 μg/mL against a broad panel of Staphylococcal and Enterococcus species, including clinical isolates of **MRSA** and **VRE**. - The study team observed a superior post-antibiotic effect for **RNP-11** versus vancomycin; investigators reported no detectable resistance emergence after thirty-three bacterial generations. - Mechanistic assays indicated a concentration-dependent, membrane-disruptive antibacterial mode of action with visible membrane damage at 5×MIC. - Authors noted **RNP-11** retained the anti-inflammatory profile of its parent NSAID, showing selective **COX-2** inhibition and suppression of pro-inflammatory cytokine production in reported assays. - In a murine skin-infection model, the compound produced significant reduction of S. aureus load; the report did not provide detailed dosing regimens or pharmacokinetic data in the abstract. - Conflict of interest disclosures included grant support and a pending patent application; the source did not report clinical development plans, regulatory milestones, or detailed safety/toxicity findings beyond the preclinical model results.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42531897/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42531897%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42531897/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42531897/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42531897/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42531897/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42531897/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42531897/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42531897%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42531897%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42531897/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42531897/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42531897/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42531897/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Elsevier Science full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--linkinghub.elsevier.com-ihub-images-PubMedLink.gif) Elsevier Science ](https://linkinghub.elsevier.com/retrieve/pii/S0223-5234\(26\)00626-4 "See full text options at Elsevier Science") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42531897/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42531897/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42531897/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42531897/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42531897/#conflict-of-interest) * [Similar articles](https://pubmed.ncbi.nlm.nih.gov/42531897/#similar) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42531897/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42531897/#substances) * [Related information](https://pubmed.ncbi.nlm.nih.gov/42531897/#related-links) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42531897/#linkout) Title & authors Abstract Conflict of interest statement Similar articles MeSH terms Substances Related information LinkOut - more resources Eur J Med Chem Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Eur+J+Med+Chem%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Eur+J+Med+Chem%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42531897/) . 2026 Nov 15:318:119181. doi: 10.1016/j.ejmech.2026.119181. Epub 2026 Jul 24. # Spermine conjugates of non-steroidal anti-inflammatory drugs as potent antibacterials against multidrug-resistant S. aureus and Enterococcus sp [Aman Kumar Mahto](https://pubmed.ncbi.nlm.nih.gov/?term=Mahto+AK&cauthor_id=42531897)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#full-view-affiliation-1 "Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research \(SPER\), Jamia Hamdard \(Deemed to be University\), New Delhi, 110062, India."), [Deepanshi Saxena](https://pubmed.ncbi.nlm.nih.gov/?term=Saxena+D&cauthor_id=42531897)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#full-view-affiliation-2 "Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh, 226031, India."), [Rahul Maitra](https://pubmed.ncbi.nlm.nih.gov/?term=Maitra+R&cauthor_id=42531897)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#full-view-affiliation-2 "Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh, 226031, India."), [Kanupriya](https://pubmed.ncbi.nlm.nih.gov/?term=Kanupriya&cauthor_id=42531897)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#full-view-affiliation-1 "Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research \(SPER\), Jamia Hamdard \(Deemed to be University\), New Delhi, 110062, India."), [Mairaj Ahmed Ansari](https://pubmed.ncbi.nlm.nih.gov/?term=Ansari+MA&cauthor_id=42531897)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#full-view-affiliation-3 "Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard \(Deemed to be University\), New Delhi, 110062, India."), [Mohammad Shahar Yar](https://pubmed.ncbi.nlm.nih.gov/?term=Yar+MS&cauthor_id=42531897)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#full-view-affiliation-1 "Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research \(SPER\), Jamia Hamdard \(Deemed to be University\), New Delhi, 110062, India."), [Sidharth Chopra](https://pubmed.ncbi.nlm.nih.gov/?term=Chopra+S&cauthor_id=42531897)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#full-view-affiliation-4 "Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh, 226031, India; Academy of Scientific and Innovative Research \(AcSIR\), Ghaziabad, 201002, India. Electronic address: skchopra007@gmail.com."), [Rikeshwer Prasad Dewangan](https://pubmed.ncbi.nlm.nih.gov/?term=Dewangan+RP&cauthor_id=42531897)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#full-view-affiliation-5 "Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research \(SPER\), Jamia Hamdard \(Deemed to be University\), New Delhi, 110062, India. Electronic address: rpdewangan@jamiahamdard.ac.in.") Affiliations Expand ### Affiliations * 1 Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), New Delhi, 110062, India. * 2 Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh, 226031, India. * 3 Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard (Deemed to be University), New Delhi, 110062, India. * 4 Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh, 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address: skchopra007@gmail.com. * 5 Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), New Delhi, 110062, India. Electronic address: rpdewangan@jamiahamdard.ac.in. * PMID: **42531897** * DOI: [ 10.1016/j.ejmech.2026.119181 ](https://doi.org/10.1016/j.ejmech.2026.119181) Item in Clipboard # Spermine conjugates of non-steroidal anti-inflammatory drugs as potent antibacterials against multidrug-resistant S. aureus and Enterococcus sp Aman Kumar Mahto et al. Eur J Med Chem. 2026. Show details Display options Display options Format Abstract PubMed PMID Eur J Med Chem Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Eur+J+Med+Chem%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Eur+J+Med+Chem%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42531897/) . 2026 Nov 15:318:119181. doi: 10.1016/j.ejmech.2026.119181. Epub 2026 Jul 24. ### Authors [Aman Kumar Mahto](https://pubmed.ncbi.nlm.nih.gov/?term=Mahto+AK&cauthor_id=42531897)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#short-view-affiliation-1 "Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research \(SPER\), Jamia Hamdard \(Deemed to be University\), New Delhi, 110062, India."), [Deepanshi Saxena](https://pubmed.ncbi.nlm.nih.gov/?term=Saxena+D&cauthor_id=42531897)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#short-view-affiliation-2 "Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh, 226031, India."), [Rahul Maitra](https://pubmed.ncbi.nlm.nih.gov/?term=Maitra+R&cauthor_id=42531897)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#short-view-affiliation-2 "Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh, 226031, India."), [Kanupriya](https://pubmed.ncbi.nlm.nih.gov/?term=Kanupriya&cauthor_id=42531897)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#short-view-affiliation-1 "Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research \(SPER\), Jamia Hamdard \(Deemed to be University\), New Delhi, 110062, India."), [Mairaj Ahmed Ansari](https://pubmed.ncbi.nlm.nih.gov/?term=Ansari+MA&cauthor_id=42531897)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#short-view-affiliation-3 "Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard \(Deemed to be University\), New Delhi, 110062, India."), [Mohammad Shahar Yar](https://pubmed.ncbi.nlm.nih.gov/?term=Yar+MS&cauthor_id=42531897)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#short-view-affiliation-1 "Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research \(SPER\), Jamia Hamdard \(Deemed to be University\), New Delhi, 110062, India."), [Sidharth Chopra](https://pubmed.ncbi.nlm.nih.gov/?term=Chopra+S&cauthor_id=42531897)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#short-view-affiliation-4 "Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh, 226031, India; Academy of Scientific and Innovative Research \(AcSIR\), Ghaziabad, 201002, India. Electronic address: skchopra007@gmail.com."), [Rikeshwer Prasad Dewangan](https://pubmed.ncbi.nlm.nih.gov/?term=Dewangan+RP&cauthor_id=42531897)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42531897/#short-view-affiliation-5 "Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research \(SPER\), Jamia Hamdard \(Deemed to be University\), New Delhi, 110062, India. Electronic address: rpdewangan@jamiahamdard.ac.in.") ### Affiliations * 1 Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), New Delhi, 110062, India. * 2 Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh, 226031, India. * 3 Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard (Deemed to be University), New Delhi, 110062, India. * 4 Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Sector 10, Janakipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh, 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address: skchopra007@gmail.com. * 5 Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), New Delhi, 110062, India. Electronic address: rpdewangan@jamiahamdard.ac.in. * PMID: **42531897** * DOI: [ 10.1016/j.ejmech.2026.119181 ](https://doi.org/10.1016/j.ejmech.2026.119181) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract The rapid emergence of multidrug-resistant (MDR) bacterial pathogens necessitates the development of new antibacterial chemotherapeutics with improved efficacy and additional therapeutic benefits. Here, in this study we have conjugated spermine with non-steroidal anti-inflammatory drugs (NSAID) as potent antibacterials with anti-inflammatory properties. Among the synthesized compounds, RNP-11, a gemini amphiphilic conjugate of spermine and flufenamic acid, exhibited potent antibacterial activity with minimum inhibitory concentrations (MICs) of 2-4 μg/mL against a broad panel of Staphylococcal and Enterococcus species, including clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE). Interestingly, RNP-11 exhibited a superior post-antibiotic effect relative to vancomycin as the RNP-11 did not induce any detectable resistance even after thirty-three generations of bacterial exposure. Mechanistic investigations revealed a concentration-dependent membrane-disruptive antibacterial mode of action, wherein RNP-11 visibly disrupts and damages bacterial membranes at 5×MIC. Furthermore, RNP-11 retained the anti-inflammatory characteristics of its parent NSAID, displaying selective COX-2 inhibition and suppression of pro-inflammatory cytokine production. This dual-action capability allows the molecule to simultaneously eradicate pathogens and mitigate the host's inflammatory response. The therapeutic viability of this hybrid strategy was successfully validated in a murine skin-infection model, where RNP-11 achieved significant bacterial reduction of S. aureus. Collectively, these findings establish spermine-NSAID conjugation as an effective strategy for developing dual-action antibacterial agents for the treatment of persistent drug-resistant infections. **Keywords:** Antimicrobial peptidomimetics; Methicillin resistant S. aureus (MRSA); Non-steroidal anti-inflammatory drugs (NSAIDs) antimicrobial resistance; Solid phase synthesis; Spermine conjugates; VRE; VRSA. Copyright © 2026 Elsevier Masson SAS. All rights reserved. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Rikeshwer Prasad Dewangan reports financial support was provided by Science and Engineering Research Board (Now ANRF). Aman Kumar Mahto reports financial support was provided by Council for Scientific and Industrial Research. Rikeshwer Prasad Dewangan has patent #Application No. 202111044966 pending to Jamia Hamdard New Delhi. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ## Similar articles * [ Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis. ](https://pubmed.ncbi.nlm.nih.gov/31096152/) Gatadi S, Gour J, Shukla M, Kaul G, Dasgupta A, Madhavi YV, Chopra S, Nanduri S.Gatadi S, et al.Eur J Med Chem. 2019 Aug 1;175:287-308. doi: 10.1016/j.ejmech.2019.04.067. Epub 2019 Apr 28.Eur J Med Chem. 2019.PMID: 31096152 * [ A new bactericidal thiourea antibiotic against drug-resistant Staphylococcus aureus with in vivo activity and no detectable resistance. ](https://pubmed.ncbi.nlm.nih.gov/42492173/) Czekanska M, Akhir A, Arts M, Kany AM, Saxena D, Maitra R, Dier A, Sokolenko I, Knopp CL, Kinsinger T, Hirsch AKH, Verma S, Schneider T, Titz A, Chopra S.Czekanska M, et al.Eur J Med Chem. 2026 Nov 15;318:119078. doi: 10.1016/j.ejmech.2026.119078. Epub 2026 Jun 19.Eur J Med Chem. 2026.PMID: 42492173 * [ Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial act
## Related Clinical Research

- [Bacterial profile and mortality predictors in necrotizing fasciitis — multicentre Uganda study](https://medichelpline.com/clinical-feed/pubmed-43049839.md) (DOI: 10.1007/s15010-026-02767-1)
- [Cinnamamide‑pyridine Quaternary Ammonium Derivative 9c Targets Bacterial Membranes Against Gram‑Po](https://medichelpline.com/clinical-feed/pubmed-42361482.md) (DOI: 10.1016/j.ejmech.2026.119100)
- [Anti‑phage defense genes mapped in vancomycin‑resistant Enterococcus faecium genomes](https://medichelpline.com/clinical-feed/biorxiv-2-functional-genomic-characterization-of-anti-phage-defense-systems-in-vancomycin.md)
- [PharmaAgent real-world test: high- vs low-autonomy agents for inpatient vancomycin dosing](https://medichelpline.com/clinical-feed/medrxiv-0-pharmaagent-a-real-world-evaluation-of-high-and-low-autonomy-agentic-systems.md)
- [Antibiotic‑Resistant and Heavy Metal–Tolerant Bacteria in Batissa violacea from Fiji’s Ba River](https://medichelpline.com/clinical-feed/plos-one-20-antibiotic-resistant-pathogens-and-heavy-metal-tolerant-bacteria-in-batissa.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.